These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 9222596)

  • 1. Influence of molecular and chemical chaperones on protein folding.
    Welch WJ; Brown CR
    Cell Stress Chaperones; 1996 Jun; 1(2):109-15. PubMed ID: 9222596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for correcting the delta F508 CFTR protein-folding defect.
    Brown CR; Hong-Brown LQ; Welch WJ
    J Bioenerg Biomembr; 1997 Oct; 29(5):491-502. PubMed ID: 9511934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical chaperones correct the mutant phenotype of the delta F508 cystic fibrosis transmembrane conductance regulator protein.
    Brown CR; Hong-Brown LQ; Biwersi J; Verkman AS; Welch WJ
    Cell Stress Chaperones; 1996 Jun; 1(2):117-25. PubMed ID: 9222597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy through chaperones: sense or antisense? Cystic fibrosis as a model disease.
    Amaral MD
    J Inherit Metab Dis; 2006; 29(2-3):477-87. PubMed ID: 16763920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of quality control pathways in human diseases involving protein misfolding.
    Welch WJ
    Semin Cell Dev Biol; 2004 Feb; 15(1):31-8. PubMed ID: 15036204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The many functions of the endoplasmic reticulum chaperones and folding enzymes.
    Halperin L; Jung J; Michalak M
    IUBMB Life; 2014 May; 66(5):318-26. PubMed ID: 24839203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacoperones as Novel Therapeutics for Diverse Protein Conformational Diseases.
    Tao YX; Conn PM
    Physiol Rev; 2018 Apr; 98(2):697-725. PubMed ID: 29442594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CFTR and chaperones: processing and degradation.
    Amaral MD
    J Mol Neurosci; 2004; 23(1-2):41-8. PubMed ID: 15126691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biosynthesis and degradation of CFTR.
    Kopito RR
    Physiol Rev; 1999 Jan; 79(1 Suppl):S167-73. PubMed ID: 9922380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrinopathies in the family of endoplasmic reticulum (ER) storage diseases: disorders of protein trafficking and the role of ER molecular chaperones.
    Kim PS; Arvan P
    Endocr Rev; 1998 Apr; 19(2):173-202. PubMed ID: 9570036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of molecular chaperones in endoplasmic reticulum (ER) quality control and ER-associated degradation (ERAD).
    Nishikawa S; Brodsky JL; Nakatsukasa K
    J Biochem; 2005 May; 137(5):551-5. PubMed ID: 15944407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular chaperones in protein quality control.
    Lee S; Tsai FT
    J Biochem Mol Biol; 2005 May; 38(3):259-65. PubMed ID: 15943899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological induction of CFTR function in patients with cystic fibrosis: mutation-specific therapy.
    Kerem E
    Pediatr Pulmonol; 2005 Sep; 40(3):183-96. PubMed ID: 15880796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction: molecular chaperones of the ER: their role in protein folding and genetic disease.
    Brooks DA
    Semin Cell Dev Biol; 1999 Oct; 10(5):441-2. PubMed ID: 10597626
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological chaperones: a new twist on receptor folding.
    Morello JP; Petäjä-Repo UE; Bichet DG; Bouvier M
    Trends Pharmacol Sci; 2000 Dec; 21(12):466-9. PubMed ID: 11121835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular chaperones in targeting misfolded proteins for ubiquitin-dependent degradation.
    Kriegenburg F; Ellgaard L; Hartmann-Petersen R
    FEBS J; 2012 Feb; 279(4):532-42. PubMed ID: 22177318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of chaperone-assisted folding and quality control in inborn errors of metabolism: protein folding disorders.
    Gregersen N; Bross P; Andrese BS; Pedersen CB; Corydon TJ; Bolund L
    J Inherit Metab Dis; 2001 Apr; 24(2):189-212. PubMed ID: 11405340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correctors promote folding of the CFTR in the endoplasmic reticulum.
    Loo TW; Bartlett MC; Clarke DM
    Biochem J; 2008 Jul; 413(1):29-36. PubMed ID: 18361776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repair of CFTR folding defects with correctors that function as pharmacological chaperones.
    Loo TW; Clarke DM
    Methods Mol Biol; 2011; 741():23-37. PubMed ID: 21594776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoring endoplasmic reticulum function by chemical chaperones: an emerging therapeutic approach for metabolic diseases.
    Engin F; Hotamisligil GS
    Diabetes Obes Metab; 2010 Oct; 12 Suppl 2():108-15. PubMed ID: 21029307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.